124 related articles for article (PubMed ID: 10530797)
1. Paradoxical effect of neuroleptic drugs on prolactin secretion by rat pituitary cell cultures.
Braghiroli L; Ponzianelli A; Mazzanti G
Life Sci; 1999; 65(14):1455-61. PubMed ID: 10530797
[TBL] [Abstract][Full Text] [Related]
2. Effect of clozapine on dopamine-induced inhibition of prolactin release from cultured rat pituitary cells.
Braghiroli L; Ponzianelli A; Fiani M; De Feo G; Cheng CY; Mazzanti G
Pharmacol Res; 1997 Mar; 35(3):173-5. PubMed ID: 9229404
[TBL] [Abstract][Full Text] [Related]
3. The effect of clozapine on prolactin secretion at the level of the lactotroph.
Lamberts SW; van Koetsveld PM; Hofland LJ
Life Sci; 1990; 46(14):1013-9. PubMed ID: 2325501
[TBL] [Abstract][Full Text] [Related]
4. Effect of estrogen and neuroleptics on prolactin secretion and immunoreactive prolactin cells.
Oliveira MC; Moraes JT; Barros HM; Barbosa-Coutinho LM
Braz J Med Biol Res; 1996 Apr; 29(4):521-5. PubMed ID: 8736119
[TBL] [Abstract][Full Text] [Related]
5. Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro.
Giacomelli S; Palmery M; Romanelli L; Cheng CY; Silvestrini B
Life Sci; 1998; 63(3):215-22. PubMed ID: 9698051
[TBL] [Abstract][Full Text] [Related]
6. The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor.
Xu R; Parlow AF; Wang Y
Brain Res; 2002 Jun; 939(1-2):95-9. PubMed ID: 12020855
[TBL] [Abstract][Full Text] [Related]
7. Effect of prolonged dopamine receptor blockade on lactotroph activity in the rat pituitary gland.
Prysor-Jones RA; Silverlight JJ; Jenkins JS
Acta Endocrinol (Copenh); 1985 Dec; 110(4):469-74. PubMed ID: 4090910
[TBL] [Abstract][Full Text] [Related]
8. Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats.
Liégeois JF; Bruhwyler J; Hendrick JC; Delarge J; Legros JJ; Damas J
Neurosci Lett; 2002 Feb; 319(1):49-52. PubMed ID: 11814651
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of dopamine antagonists on prolactin secretion from cultured rat pituitary cells.
Denef C; Follebouckt JJ
Life Sci; 1978 Aug; 23(5):431-5. PubMed ID: 29185
[No Abstract] [Full Text] [Related]
10. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
11. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.
Besser GM; Delitala G; Grossman A; Stubbs WA; Yeo T
Br J Pharmacol; 1980; 71(2):569-73. PubMed ID: 6110459
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic stimulation of prolactin release.
Denef C; Manet D; Dewals R
Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
[TBL] [Abstract][Full Text] [Related]
13. DNA synthesis and depletion of prolactin in the pituitary gland of the male rat.
Lloyd HM; Jacobi JM; Meares JD
J Endocrinol; 1978 Apr; 77(1):129-36. PubMed ID: 641429
[TBL] [Abstract][Full Text] [Related]
14. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay.
Jarry H; Leonhardt S; Gorkow C; Wuttke W
Exp Clin Endocrinol; 1994; 102(6):448-54. PubMed ID: 7890021
[TBL] [Abstract][Full Text] [Related]
15. Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.
Bowden CR; Voina SJ; Woestenborghs R; De Coster R; Heykants J
J Pharmacol Exp Ther; 1992 Aug; 262(2):699-706. PubMed ID: 1380082
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL
Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
[TBL] [Abstract][Full Text] [Related]
17. Aflatoxins inhibit prolactin secretion by rat pituitary cells in culture.
Abdel-Haq H; Giacomelli S; Palmery M; Leone MG; Saso L; Silvestrini B
Drug Chem Toxicol; 2000 May; 23(2):381-6. PubMed ID: 10826104
[TBL] [Abstract][Full Text] [Related]
18. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
[TBL] [Abstract][Full Text] [Related]
19. Chronic effect of antidopaminergic drugs or estrogen on male wistar rat lactotrophs and somatotrophs.
Oliveira MC; Messinger HP; Tannhauser M; Barbosa-Coutinho L
Braz J Med Biol Res; 1999 Dec; 32(12):1561-4. PubMed ID: 10585641
[TBL] [Abstract][Full Text] [Related]
20. Effect of ergovaline, loline, and dopamine antagonists on rat pituitary cell prolactin release in vitro.
Strickland JR; Cross DL; Birrenkott GP; Grimes LW
Am J Vet Res; 1994 May; 55(5):716-21. PubMed ID: 8067623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
